Metabolic Dysfunction-Associated Steatotic Liver Disease in Children
Clinics in Liver Disease · 2026-11 · 30 (4) · 987-1007
DOI: 10.1016/j.cld.2026.07.009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Liver Disease, 2026-11. Verfasst von Toshifumi Yodoshi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology, Pancreatology, and Nutrition, Department of Pediatrics, Stead Family Children's Hospital, University of Iow…. Hauptthemen laut MEDLINE: Fatty Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit nennt 75 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease among children and adolescents worldwide. Pediatric MASLD is associated with significant morbidity during childhood, including progressive liver fibrosis and incident diabetes, and significantly increases risk of premature mortality in early adulthood. In comparison to MASLD in adults, youth-onset MASLD exhibits distinct histologic patterns, lacks well-validated noninvasive tests for risk stratification and approved pharmacotherapy, and may carry higher risk of long-term liver-related mortality. Critical areas of unmet need include improving rates of recommended screening, development of pediatric-specific risk stratification tools and developing more effective prevention and treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology, Hepatology, Pancreatology, and Nutrition, Department of Pediatrics, Stead Family Children's Hospital, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA; Division of Gastroente…
- Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Electronic address: stavra.xanthakos@cchmc.org.
Zitieren
APA
Yodoshi, T., & Xanthakos, S. (2026). Metabolic Dysfunction-Associated Steatotic Liver Disease in Children. Clinics in Liver Disease, 30(4), 987-1007. https://doi.org/10.1016/j.cld.2026.07.009
Vancouver
Yodoshi T, Xanthakos S. Metabolic Dysfunction-Associated Steatotic Liver Disease in Children. Clinics in Liver Disease. 2026;30(4):987-1007. doi:10.1016/j.cld.2026.07.009
BibTeX
@article{Yodoshi2026,
author = {Yodoshi, Toshifumi and Xanthakos, Stavra},
title = {Metabolic Dysfunction-Associated Steatotic Liver Disease in Children},
journal = {Clinics in Liver Disease},
year = {2026},
volume = {30},
number = {4},
pages = {987--1007},
doi = {10.1016/j.cld.2026.07.009}
}
EUVIMED